AGENUS INC | 4,104 Euro | +0,028 +0,69 % | |
| WKN: A1JLKZ ISIN: US00847G7051 Ticker-Symbol: AJ81 | Frankfurt | 25.05.12 | 18:22 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 09.05. | AGENUS INC - 10-Q, Quarterly Report | 2 | SEC Filings | |
| 17.04. | Agenus Inc Plans To Move Forward With Randomized Trial Evaluating Efficacy Of HSPPC-96 In Glioblastoma Patients | 4 | Benzinga.com | |
| 08.03. | ANTIGENICS INC /DE/ - 10-K/A, Annual Report | - | SEC Filings | |
| 06.03. | ANTIGENICS INC /DE/ - 10-K, Annual Report | - | SEC Filings | |
| 05.03. | Agenus (AGEN), Glaxo (GSK) Amends, Expands QS-21 License Agreement | 3 | StreetInsider.com | |
| 20.12. | Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines / Agreement Covers the Launch of the Oncophage(R) Vaccine, Approved in Russia | 38 | MarketWire | |
| LEXINGTON, MA and MOSCOW -- (Marketwire) -- 12/20/11 -- Agenus Inc. (NASDAQ: AGEN), a biotechnology company working to develop treatments for cancers and infectious diseases, and NewVac LLC (a subsidiary... Mehr lesen zu: Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines / Agreement Covers the Launch of the Oncophage(R) Vaccine, Approved in Russia | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
